JPRN-jRCT2080222567已完成2 期
KRP-AM1977Y Phase II Clinical Study _ To assess efficacy, safety and pharmacokinetics of KRP-AM1977Y in the patients with community acquired pneumonia
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 84
研究概览
简要总结
The cure rates at the test-of-cure were more than 90% in both the KRP-AM1977Y 75 mg and the 150 mg groups. A high clinical efficacy was observed in both groups.In the safety assessment, no major problem was observed in both administration groups. No clinically significant finding was reported in both treatment groups.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 79age old（—）
- 性别
- All
入选标准
- •Community acquired pneumonia with clear infectious symptoms
排除标准
- •- Pneumonia patient except the community-acquired pneumonia
- •- Patient with serious functional disorder that would unsuitable for the study
- •- Patient showing the tendency to improve pneumonia symptoms by other agents, etc.
研究者
相似试验
已完成
2 期
KRP-AM1977X Phase II Clinical StudyMild to moderate community acquired pneumonia (including Mycoplasma pneumonia, Chlamydia Pneumonia, or Legionella pneumonia)JPRN-jRCT2080222226Kyorin Pharmaceutical Co.,LTD129
已完成
3 期
KRP-AM1977X Phase III Comparative Study (Community acquired pneumonia)JPRN-jRCT2080222860Kyorin Pharmaceutical Co.,LTD277
已完成
3 期
A Phase III, comparative study of KRP-AM1977Y in community- acquired pneumoniaJPRN-jRCT2080223246Kyorin Pharmaceutical Co.,LTD286
已完成
3 期
KRP-AM1977X Phase III Comparative Study (sinusitis)Sinusitis (severity of infection: moderate to severe)JPRN-jRCT2080222862Kyorin Pharmaceutical Co.,LTD279
已完成
1 期
KRP-AM1977X QT/QTc studyHealthy volunteersJPRN-jRCT2080222958Kyorin Pharmaceutical Co., Ltd.60